NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioArmix

BioArmix

Private
IsraelHealthcare & Life Scienceshttps://www.bioarmix.com/

Last Round

Grant

Oct 16, 2025

Total Funding Raised

$23,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BioArmix is an agricultural chemicals company that manufactures natural biocontrol agents intended to protect crops from bacterial diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Blockchain Infrastructure, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

biocontrol agentbiopesticidepredatory bacteriacrop protectionagricultural biotechagritechagtechbiological crop protectionmicrobial pesticidebiocontrolsustainable agricultureag bioencapsulated bacteriapowder formulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioArmix Comparables

Compare BioArmix with similar companies based on industry and business-model similarity.

BioArmix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EcoPhage
34%

BioArmix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 16, 2025
Pre SeedJan 1, 2024

Key People

Founding team and executive leadership

Tzvi Zvirin

Co-Founder & CEO

Founding Team

BioArmix Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 16, 2025

    $23K grant received from EIT Food Accelerator Network.

  • Jan 1, 2024

    Secured Pre Seed funding from Galil Ofek Innovation and others.

BioArmix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioArmix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioArmix's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range6
Year Founded2023
Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.